Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development
Search Refinements
Search Results: Drug Discovery & Development
1-15 of 5696 results
Inozyme Pharma secures $49m funding for rare disease therapies
Inozyme Pharma, which is developing novel medicines to treat rare diseases of calcification, affecting soft tissues and bone, has raised a $49m Series A financing.
Drug Research > Drug Discovery & Development > News
Purdue Pharma to invest in oncology research and development
Purdue Pharma says that it has finalized major oncology related investments as part of its move to diversify its scientific research into areas of high unmet medical need.
Drug Research > Drug Discovery & Development > News
Bayer and Loxo Oncology to develop and commercialize two cancer therapies
Bayer has entered into an exclusive global collaboration with Loxo Oncology for the development and commercialization of larotrectinib (LOXO-101) and LOXO-195.
Drug Research > Drug Discovery & Development > News
EMA grants PRIME designation for Mereo’s BPS-804 to treat osteogenesis imperfecta
Mereo BioPharma Group’s BPS-804 has been granted PRIority MEdicines (PRIME) designation from the European Medicines Agency (EMA) for the treatment of osteogenesis imperfecta (OI), or "brittle bone disease."
Drug Research > Drug Discovery & Development > News
Research indicates potential treatment for autism and intellectual disability
A University of Nebraska Medical Center researcher and his team at the Munroe-Meyer Institute (MMI) made a breakthrough in finding the mechanism and a possible therapeutic fix for autism and intellectual disability
Drug Research > Drug Discovery & Development > News
Sanofi to develop Principia’s MS drug candidate in $805m deal
By PBR Staff Writer
Sanofi has agreed to develop Principia Biopharma’s Bruton’s tyrosine kinase (BTK) inhibitor (PRN2246) for the treatment of multiple sclerosis (MS) and possibly other central nervous system (CNS) diseases.
Drug Research > Drug Discovery & Development > News
Boehringer, MiNA Therapeutics partner to develop novel treatments for fibrotic liver diseases
By PBR Staff Writer
Boehringer Ingelheim has entered into collaboration and licensing agreement with MiNA Therapeutics for the development of novel treatments to treat fibrotic liver diseases.
Drug Research > Drug Discovery & Development > News
Cerenis Therapeutics acquires Lypro Biosciences
Cerenis Therapeutics has acquired Lypro Biosciences to expanding its HDL strategy into immuno-oncology and chemotherapeutic drug delivery.
Drug Research > Drug Discovery & Development > News
New international consortium formed to speed up drug discovery in kidney diseases
By PBR Staff Writer
A new international consortium, including academic institutions such as the Universities of Bristol and Cambridge and drugmaker Evotec, has been established to enhance the discovery of drugs to treat kidney diseases.
Drug Research > Drug Discovery & Development > News
Spark Therapeutics, Pfizer amend license deal for investigational SPK-9001 in hemophilia B
Spark Therapeutics and Pfizer have entered into an amendment to their license agreement for SPK-9001, an investigational gene therapy for hemophilia B.
Drug Research > Drug Discovery & Development > News
Xenetic signs sublicense deal related to PolyXen technology with Baxalta
Xenetic Biosciences has entered into a Right to Sublicense Agreement with Baxalta, Baxalta, and Baxalta (collectively, with their affiliates, “Baxalta”), wholly-owned subsidiaries of Shire.
Drug Research > Drug Discovery & Development > News
Boehringer, Dicerna partner on RNAi treatment for NASH
By PBR Staff Writer
Boehringer Ingelheim and Dicerna Pharmaceuticals have partnered to develop treatments for chronic liver diseases including Nonalcoholic Steatohepatitis (NASH).
Drug Research > Drug Discovery & Development > News
Amgen to buy Japanese joint venture
By PBR Staff Writer
Amgen has entered an agreement to acquire Kirin-Amgen, its joint venture (JV) with Japan-based Kirin Holdings for $780m.
Drug Research > Drug Discovery & Development > News

PBR Supplier Recommendations

Biovian - cGMP Contract Manufacturing of Biopharmaceuticals
Biovian is a dynamic and effective new generation one-stop-shop CMO in cGMP contract manufacturing of biopharmaceuticals. Biovian's services cover the full range from antigen isolation, expression, vector construction, cell line cultivation, cGMP protein purification to product fill and finish.... Drug Research > Drug Discovery & Development > Suppliers
Vetter Pharma International - High-Quality Aseptically Pre-Filled Injection Systems
From preclinical development through commercial supply.... Drug Research > Drug Discovery & Development > Suppliers
Patient Focused Medicines Development (PFMD)
Patients Focused Medicine Development (PFMD) is an open, global and collaborative coalition of patient organisations and advocates, pharma and life sciences industry, HTA bodies, national advisory organisations and regulators. Their aim is to drive meaningful patient engagement by co-creating a standardised and globally adopted framework for patient engagement, so that patients' needs and priorities are at the core of medicines development and lifecycle. PFMD was established in 2015 and currently counts 24 members. Their 'Pledge to Patients' campaign encourages members of the medical community to commit to measurable actions to improve patient engagement.... Drug Research > Drug Discovery & Development > Suppliers
See more

PBR White Paper Recommendations

Vetter: A unique blend of expertise By Vetter Pharma International
From clinical development to commercial production.... Drug Research > Drug Discovery & Development > White Papers Vetter Development Service - Supporting your compound’s success By Vetter Pharma International
A unique blend of expertise for clinical manufacturing.... Drug Research > Drug Discovery & Development > White Papers Vetter Commercial Manufacturing - Delivering results across the production chain By Vetter Pharma International
A unique blend of capabilities for aseptic fill and finish.... Drug Research > Drug Discovery & Development > White Papers Vetter Packaging Solutions - Delivering your product's potential By Vetter Pharma International
A unique blend of resources for filling and packaging.... Drug Research > Drug Discovery & Development > White Papers Vetter Development Service Chicago By Vetter Pharma International
Our premium manufacturing and clinical supply site near Chicago, Illinois, has the people, processes, and technology to serve pharma and biotech companies of every size with customizable solutions for drug compounds in any stage from Preclinical Testing to Phase II and beyond.... Drug Research > Drug Discovery & Development > White Papers See more
1-15 of 5696 results